Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TS-172 in Hyperphosphatemia Patients on Hemodialysis
NCT05699239Phase 2Completed
- Sponsor
- Taisho Pharmaceutical
- Start
- Feb 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TS-172 in hyperphosphatemia, sponsored by Taisho Pharmaceutical. Started Feb 2023; status: completed.
02
Drugs
TS-172
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT05699239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05699239.